Roche is investigating one case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple sclerosis (MS) after treatment with ocrelizumab (Ocrevus). The company said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results